In short. A change that may or may not have occurred cannot be measured, and an unmeasurable benefit cannot be weighed against a real risk.
Key points
- A proxy is used because the real outcome is impractical to measure, and that is a reasonable methodological compromise.
- What is not reasonable is presenting the proxy as the outcome, which turns a change in a marker into a claim about how a face will age.
A prevention claim is not tested in the same way as a treatment claim, and understanding why explains most of the evidence gap in this category.
The outcome is an absence
A treatment claim is tested by measuring a change that occurred. A prevention claim is tested by measuring a change that did not, which means comparing people who were treated with people who were not, over a period long enough for the avoided change to have appeared, with an appearance graded consistently enough to compare. In facial ageing that period is measured in years. Studies of that design exist in medicine for outcomes that can be counted, such as fractures or cardiovascular events, and they do not exist for how a face looks.
Proxies, and what they can carry
Because the real outcome cannot be measured, studies in this category measure proxies: a change in a marker in a tissue sample, a measurement of skin thickness or elasticity, a score from an observer looking at photographs taken months apart. Each of those is a real finding. None of them is the avoided change the claim is about, and the gap between a proxy and the outcome is where the overstatement lives.
A measurable substitute is still a substitute
A proxy is used because the real outcome is impractical to measure, and that is a reasonable methodological compromise. What is not reasonable is presenting the proxy as the outcome, which turns a change in a marker into a claim about how a face will age.
The baseline problem
There is a further obstacle when the person has no findings. Without a finding there is nothing to record, so a baseline cannot be established and a comparison cannot be made even in principle. The claim is not merely untested for that person; it is untestable, which is a different category of problem and the one that makes this subject distinctive.
Why the claim survives anyway
Because nothing can contradict it. A person treated now whose skin looks good in ten years cannot know whether the treatment was responsible, and neither can anyone else, because the comparison was never made. The claim is therefore immune to refutation by experience, which is precisely why it persists without evidence rather than fading from use.
What a prevention study would need
- Treated and untreated groups, comparable at the start, followed for years.
- An agreed way of grading the appearance that is reliable between observers.
- Assessment by people who do not know which group each person was in.
Those three requirements are what make this study difficult, and none of them is unreasonable to ask for before a claim is treated as settled.
Frequently asked questions
Why can a prevention claim not simply be tested like any other?
Because the outcome is an absence. A treatment claim is tested by measuring a change that occurred; a prevention claim is tested by measuring a change that did not, which requires a comparison group followed for years and an outcome graded consistently. That design is expensive and slow, and in facial ageing it has not been run.
What is the difference between a proxy and the outcome claimed?
A proxy is something measurable that stands in for the thing you care about, such as a marker in a tissue sample. The outcome claimed is an avoided change in how the face looks, years later. A change in a proxy is a real finding and it is not the same as the outcome, and studies in this category usually report the proxy.
Does the absence of evidence mean prevention is impossible?
No, and the distinction matters. Sun protection and not smoking do prevent a substantial part of what skin ageing looks like, and that is established. The claim here is narrower: that for the treatments sold as prejuvenation, the design that could show a preventive benefit has not been run, and where the person has no findings it could not be run at all.
Risks & Limitations
- A face with no findings has no measurable baseline, so a preventive benefit cannot be demonstrated while the risks of treatment remain real.
- Nothing is approved with a preventive indication for facial ageing; approvals are for treating a change that is already present.
- Sun protection and not smoking are the only preventive measures with substantial support, and neither needs a clinical treatment.
- Treating early or maintaining a result is not prevention, and repeated treatment accumulates the labelled risks.
- A claim that nothing could contradict is a claim that cannot be supported either, and this category's claims are of that kind.
When to Seek Care
- A mole or patch that is changing in size, shape or colour — have it assessed by a clinician.
- A lesion that bleeds, itches or will not heal — have it assessed by a clinician.
- Blistering, crusting or pigment change that follows a device treatment — have it assessed by a clinician.
- Severe pain, dusky or mottled skin, or a change in vision after an injection — seek emergency care immediately.
References & Further Reading
- World Health Organization (WHO) — ultraviolet radiation and skin cancer prevention guidance
- U.S. Food and Drug Administration (FDA) — approved products and devices and their labelled indications
- National Medical Products Administration (NMPA, China) — approved products and their indications
- Cochrane Library — systematic reviews of photoprotection and topical treatments
- Chinese Medical Association Dermatology Branch — clinical guidance
This page is a review of published evidence and regulation, not medical advice, and it does not cite individual studies. It is not a booking page and it does not recommend a treatment, for or against. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.